Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting
- 31 August 2009
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 92 (2), 499-507
- https://doi.org/10.1016/j.fertnstert.2008.06.039
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Serum anti-mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cyclesHuman Reproduction, 2007
- Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significanceFertility and Sterility, 2007
- Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?Fertility and Sterility, 2006
- Paradoxical ovarian stimulations in the use of LHRH analogsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
- Rescue of menotrophin cycles prone to develop ovarian hyperstimulationBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Antigonadotropic Actions of GnRH Agonist on Ovarian Cells in vivo and in vitroJournal of Steroid Biochemistry, 1985
- GnRH agonist-induced inhibitory and stimulatory effects during ovarian follicular maturationMolecular and Cellular Endocrinology, 1984
- Dissociation between the direct stimulatory and inhibitory effects of a gonadotropin-releasing hormone analog on ovarian functionsMolecular and Cellular Endocrinology, 1983
- Biphasic Effect of Gonadotropin Releasing Hormone on Progestin Secretion by Rat Granulosa CellsBiology of Reproduction, 1983
- GnRH receptors in cultured rat granulosa cells: Mediation of the inhibitory and stimulatory actions of GnRHMolecular and Cellular Endocrinology, 1982